Drug Search Results
More Filters [+]

CT-38

Alternative Names: ct-38, ct38, ct 38
Latest Update: 2024-01-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: CRFR Agonist

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: LUCINDA BATEMAN, MD
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for CT-38

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Encephalomyelitis|Myalgia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

InTiME

P2

Completed

Encephalomyelitis|Myalgia

2019-04-30

Recent News Events